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A B S T R A C T   
The term „nutritional cognitive neuroscience” was recently established to define a research field focusing on the 
impact of nutrition on cognition and brain health across the life span. In this overview, we summarize the robust 
evidence on the role of carotenoids as micronutrients with different biological properties in persons with 
cognitive (pre)frailty. As neurodegenerative processes during aging occur in a continuum from brain aging to 
dementia, we propose the name „nutritional cognitive neuroscience of aging“ to define research on the role of 
nutrition and micronutrients in cognitive frailty. Further studies are warranted which integrate carotenoid in-
terventions in multidomain, personalized lifestyle strategies.   
1. Introduction 
The term „Nutritional cognitive neuroscience” was recently estab-
lished to define a rapidly expanding interdisciplinary field of research 
that seeks to understand nutrition’s impact on cognition and brain 
health across the life span [1]. Indeed, nutrition, in its broad range of 
aspects from specific nutrients to whole diets, has been shown to affect 
brain structure and function. Therefore, nutritional cognitive neurosci-
ence includes both pathophysiological investigations and nutritional 
intervention strategies in brain ageing and disease. The field has recently 
gained attention mainly due to two aspects, both related to the current 
demographic explosion with an impressive increase of the aging popu-
lation. The first is the growing need to maintain cognitive integrity for 
healthy and active aging, in wellbeing and robustness [2,3]. The second 
is the rapidly increasing prevalence of and attention to age-related 
cognitive decline and dementias including mild cognitive impairment 
(MCI) [4] and Alzheimer disease (AD) [2,3]. Cognitive decline with and 
without dementia causes major public health concerns based on the fact 
that dementia is not curable. This is due to late diagnosis and a multi-
faceted pathophysiology, called multifactoriality. As multifactoriality 
increases with increasing age, the latter is the main risk factor for 
cognitive impairment and the large majority of dementia patients are 
old and very old, attention is shifted towards need of early diagnosis of 
cognitive changes and to slowing down their progression. Age-related 
cognitive decline including subjective cognitive impairment (SCI) [5] 
and MCI are object of a large body of investigations prompted at iden-
tifying the best possible preventive strategies. While the challenged 
search for effective anti-dementia drugs is ongoing, studies on the role of 
vascular- and lifestyle-related preventive strategies show that vascular 
risk control and lifestyle improvement are indeed able to slow down the 
progression of cognitive impairment [3,6–9]. Among lifestyle in-
terventions, cognitive training programs, physical exercise interventions 
and dietary strategies have gained a great deal of attention recently [7,9, 
10]. 
Several of these studies have been based upon the evidence that 
oxidative stress, a critical pathophysiological mechanism in aging [2, 
11–14] as well as in the onset and progression of cognitive impairment 
[15–19], can be substantially influenced by physical activity and 
nutrition. Indeed, several biomarkers of oxidative stress and indicators 
of antioxidant micronutrient defense against free radicals have been 
shown to be associated with cognitive impairment with and without 
dementia [15–19]. Although the results of these studies are interesting, 
the interactions between the different components of lifestyle across the 
course of cognitive impairment have been not clearly identified yet. 
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The aim of this overview is to summarize existing knowledge in a 
field typically falling within the nutritional cognitive neuroscience, 
collected by the authors over several years of experience and concerning 
the analysis of a specific group of nutrient biomarker patterns, those 
related to carotenoids, coupled with modern metrics of cognitive per-
formance and indices of brain health in advanced age. By integrating 
cutting-edge techniques from nutritional science and cognitive neuro-
science, the newly established field of nutritional cognitive neuroscience of 
aging can be informed by both long-lasting research and advanced tar-
geted understanding on the multifaceted relationship between nutrition 
and brain aging. 
2. Deregulation of redox balance and neurodegeneration 
Nutrition and antioxidant micronutrient function in cognitive 
neuroscience emerged largely from the evidence of the role of oxidative 
distress and eustress in brain aging, neurodegeneration and age-related 
cognitive decline [17,20]. While the latter is acknowledged, conflicting 
results from interventional studies are due essentially to the multi-
factoriality and heterogeneity of the aging process including brain 
aging, which hinders the adequate disentaglement of one mechanism 
from other „pillars“ [21]. A paradigm shift necessary to the under-
standing of nutritional cognitive neuroscience consists of the well 
known, but largely neglected, fact that the main risk factor for 
age-related diseases including dementia is age and that the pathophys-
iology of aging with its multiple age-related changes strikingly re-
sembles the characteristics of the aging brain, through a continuum from 
normal cognitive function to dementia [22,23]. In particular, the path-
ophysiology of age-related cognitive impairment and dementia is 
multifactorial, extremely complex and spans from traditional amyloid-β- 
and τ-hypotheses to genetic factors, to a lifelong exposure to the 
disequilibrium between the multitude of vascular and lifestyle protec-
tive and risk factors known [23]. In other words, main age-related 
neurodegenerative characteristics including structural, cellular, molec-
ular, biochemical, vascular changes reflect intrinsic and extrinsic fea-
tures of the aging process itself and are associated to cognition correlates 
[3,23]. Across the biomolecular to phenotypical to clinical manifesta-
tions, all age-related changes explain memory loss, impairment of other 
cognitive domains and neurological and neuropsychiatric systems. For 
the same reason, motoric alterations, posture, balance and gait disor-
ders, sleep disturbances, sensory decrements, personality changes and 
mood disorders are part of the dementia features. 
Within this complexity, the central nervous system (CNS), as a tissue 
that is highly dependent on O2, is particularly sensitive to changes in O2 
levels and to the elevated production of derivatives of molecular oxygen 
(which are otherwise normally formed as an attribute of aerobic life), 
reactive oxygen species (ROS). The elevated formation of different ROS 
is termed ‘oxidative distress’, leads to molecular damage and is the 
pathologic counterpart of ‚oxidative eustress‘ - the equilibrium between 
ROS at physiological levels and their central role in redox signalling via 
different post-translational modifications [20]. 
Deregulation of redox balance as oxidative distress is strongly linked 
to neurodegeneration, including major long-term degenerative diseases 
such as AD, Parkinson disease, Huntington disease and amyotrophic 
lateral sclerosis [24]. Insults to the CNS, such as accumulation of protein 
aggregates associated with neurodegenerative diseases, cause oxidant 
generation — involving both neurons and microglia, the main phago-
cytes in the brain that serve as neuron-supporting cells. Generally, this 
response is meant to be protective by clearing debris and supporting 
neuronal survival. However, in some cases microglia become over-
activated and overproduce reactive oxygen species (ROS) and reactive 
nitrogen species, thereby leading to neuroinflammation and impeding 
neuronal and oligodendroglial survival [25]. Furthermore, 
ischaemia-associated factors cause neuronal autotoxicity and break-
down of the blood–brain barrier [8,26,27]. The pleiotropy of ROS effects 
include several mechanisms investigated by transcriptomic, 
metabolomic, biochemical, immunohistochemical and behavioural an-
alyses; there is also evidence that oxidants are mediators of psycholog-
ical stress responses and that chronic psychological stress exposure 
promotes oxidative damage of nucleic acids and lipids, which could 
contribute to stress-induced ageing and mediate psychobiological 
resilience to oxidative damage in case of mild stress (reviewed in 
Ref. [20]). 
3. Carotenoids and cognitive frailty 
Tissue carotenoids are robust biomarkers of dietary exposure, 
occurring as natural lipophilic yellow-orange pigments present in 
various organisms, such as plants, animals, and microorganisms. The 
orange color of carrots and the red color of tomatoes are due to their 
carotenoid components. Plant, algae, and fungi produce >600 different 
types of carotenoids, while animals obtain carotenoids from food since 
they cannot synthesize them. About 40 different carotenoids are found 
in human organisms with α- and β-carotene, β-cryptoxanthin, lycopene, 
lutein, zeaxanthin the most prominent (Fig. 1). In addition to dietary 
supply, carotenoid bioavailability, metabolism and distribution depends 
on individual host factors including diseases, lifestyle, sex, age, and 
genetic makeup [28]. Together these factors determine an individual 
carotenoid pattern in the human blood and tissues and influence the 
generation of carotenoid metabolites and their distribution. 
Consumption and levels of circulating carotenoids have been linked 
to health effects in context with several age-related diseases as well as to 
cognitive and physical performance [29]. While several mechanisms of 
action have to be disclosed yet, the biochemistry of carotenoids is 
important to understand their beneficial properties. 
Biological properties of carotenoids are closely related to their 
unique structure which also determines their physicochemical charac-
teristics. Carotenoids usually consist of 8 isoprenoid and thus contain 40 
carbon atoms. Most of them are composed of a central chain with con-
jugated double bonds substituted with various cyclic and acyclic sub-
stituents [30]. The polyene chain is responsible for the color of the 
compounds and determines their antioxidant activity. Double bonds of 
carotenoids may occur in the cis/trans (E/Z) isomeric form. However, of 
the numerous possible isomers the all-trans configuration, selected 
mono and poly-cis isomers are preferentially formed. Carotenoids which 
are composed only of carbon and hydrogen atoms are very lipophilic and 
tend to accumulate in lipophilic surroundings like membranes or lipo-
proteins. Xanthophylls, a subgroup of carotenoids which carry at least 
one oxygen atom are somewhat less lipophilic and the functional residue 
has impact on antioxidant activity, biochemical effects and spatial 
orientation. In membranes xanthophylls like lutein can basically take 
two different orientations. When the OH-groups are located at opposite 
hydrophilic surfaces they span the double layer [31]. When both 
OH-groups are fixed at the same hydrophilic surface the orientation of 
the xanthophyll is perpendicular to hydrophobic core. Carotenoids also 
tend to aggregate in membranes. Orientation and aggregation of carot-
enoids in biological membranes has impact on membrane fluidity, sta-
bility, permeability, and its biological function as a signaling platform; e. 
g. formation of lipid rafts. It has been suggested that specific 
xanthophyll-membrane interactions are relevant for proper function of 
neural membranes which might explain the selective occurrence of 
lutein and zeaxanthin in brain and retina [32]. 
3.1. Carotenoids as antioxidants 
Experimental data have proven that carotenoids are efficient lipo-
philic antioxidants in vivo [33]. Upon exposure of polyunsaturated acids 
to free radicals like the hydroxyl or hydrogen radical, lipid peroxidation 
is induced and a number of secondary reactive oxygen species such as 
lipid hydroperoxides, cyclic peroxides or peroxyl radicals are generated. 
In further reaction sequences reactive aldehydes are formed. Lipid per-
oxidation and chemical reactions of peroxidation products impair 
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membrane properties and interfere with the proper function of relevant 
biomolecules, mainly proteins. Carotenoids exhibit antioxidant proper-
ties that may interfere with lipid peroxidation. Although the basic 
chemistry of carotenoid radical interaction is not completely under-
stood, radical scavenging usually involves the transfer of a hydrogen 
atom or electron, yielding a carotenoid radical or carotenoid radical 
ions, respectively. 
Carotenoid radicals are thought to be stabilized via electron deloc-
alisation over the entire system of π-bonds. In contrast to other antiox-
idants, carotenoids are destroyed in this process and cannot be 
regenerated like vitamin E. The contribution of carotenoid-dependent 
radical scavenging to entire in-vivo antioxidant network is still a mat-
ter of debate but also indirect effects of carotenoids linked to activation 
of antioxidant defense enzymes are likely important [34]. There is evi-
dence that carotenoids act as prooxidants under specific conditions and 
then contribute to an oxidative load. Antioxidant versus prooxidant 
behaviour depends on the concentration of the carotenoid itself, oxygen 
tension and chemical surroundings. It has been postulated that either 
too low or too high concentrations of the compounds are unfavourable. 
Thus, benefits and risks have been related to the intake of carotenoids 
with both anti- and prooxidative properties [35] and optimal carotenoid 
levels are required for antioxidant activity in cells and tissues. 
Carotenoids with an extended system of conjugated double bonds are 
very efficient quenchers of singlet molecular oxygen and excited triplet 
state molecules [33]. They are part of the light-harvesting complex in 
plants and among other tasks responsible for the prevention oxidative 
damage due to light induced formation of reactive oxygen species. Upon 
physical quenching of excited state compounds carotenoids remain 
intact and undergo several cycles before they are destroyed in chemical 
reactions. Singlet oxygen is also generated in the human organism 
especially in light exposed tissue when suitable sensitizers are present. 
However, also the light-independent chemical generation of singlet 
oxygen has been described [36]. 
Absorption of visible light in the range of about 450 nm is a typical 
for carotenoids with nine conjugated double bonds. The retinal xan-
thophylls lutein and zeaxanthin are selectively taken up and comprise 
the major macular pigments. Due to their absorption properties they are 
efficient filters for high-intensity, short-wavelength visible light which 
adds to their antioxidant function and contributes to the protection 
against light-induced oxidative stress [37]. Lutein and zeaxanthin are 
suggested to play a role in the prevention of age-related macular 
degeneration [37]. 
3.2. Vitamin A and carotenoid metabolites 
Carotenoids which carry at least one beta ionone ring are precursors 
of vitamin A and considerably contribute to human vitamin A supply. 
Due to its structure, β-carotene is the only carotenoid which can be 
cleaved to yield two molecules of all-trans-retinal [38]. Cleavage of the 
central double bond is catalysed by the enzyme β-carotene-15, 
15’-oxygenase (BCO1), which also takes α-carotene, lycopene and some 
apo-carotenals as substrates [39]. Recently, it has been confirmed that 
the enzymatic activity of β-carotene-oxygenase 2 (BCO2), which con-
verts carotenoids into more polar metabolites, is conserved in humans. 
This enzyme is expressed at high levels in human retinas and plays a role 
in controlling carotenoid homeostasis. Its activity may help to explain 
why the apocarotenoid substrates e.g. xeaxanthin, achieve a steady state 
level after supplementation and it provides a mechanism for the catab-
olism of oxidized carotenoid metabolites through asymmetric cleavage 
by the generating β-ionone and β-apo-10′-carotenal ([40] JBC 295, 
Fig. 1. Chemical structures of selected carotenoids and retinoids.  
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15553). BCO2 was also effective in protecting human cell lines from 
oxidative stress induced by carotenoids that have been associated with 
adverse health effects in animal models and their offspring. 
Retinal is the key molecule in the vision process but also further 
metabolized to retinoic acid which in its all-trans and 9-cis configuration 
binds as a ligand to the retinoic acid receptor (RAR) family. To form a 
functional transcription factor the RAR must dimerize with the retinoic 
X receptor (RXR) which is activated by the ligand 9-cis retinoic acid. 
RAR/RXR dimer control the transcription of genes associated with cell 
differentiation, proliferation, apoptosis, or embryonic development. 
Apart from the RAR a number of other nuclear receptors form hetero 
dimers with RXR for activation. Among them are peroxisome 
proliferator-activated receptors (PPARs), liver X receptors (LXRs), the 
farnesoid X receptor (FXR), the pregnane X receptor (PXR) and the 
constitutive androstan receptor (CAR) which play important roles in the 
regulation of growth and adaptation of energy metabolism as well as 
inflammation and inflammaging [41]. Thus, RXR is a key player in this 
regulatory machinery and it has been hypothesized that controlling the 
activity of RXR is an attractive approach to address cellular functions 
which are affected in diseases such as cancer, diabetes, Alzheimer’s 
disease or Parkinson’s disease [42]. Although the role of 9-cis retinoic 
acid as natural ligand of the RXR is still not completely understood, tight 
regulation of its cellular levels via control of retinoic acid synthesis and 
metabolism of carotenoid precursors are mandatory. Inadequate levels 
of this regulatory molecule likely disturb important cellular signalling 
pathways. Thus, the fate of the 9-cis β-carotene geometrical isomers is of 
considerable interest. Although our knowledge on factors that influence 
the metabolism of β-carotene and its geometrical isomers in vivo is 
limited, shifts in carotenoid levels or the carotenoid pattern might have 
impact and influence the response of the organism. 
Retinoids and their parent carotenoids have also been shown to 
stimulate gap junctional intercellular communication (GJIC) which has 
been discussed as a possible biochemical mechanisms underlying the 
cancer-preventive properties of these compounds [43]. Among the 
major dietary carotenoids β-carotene, cryptoxanthine, zeaxanthin and 
lutein efficiently induce GJIC. 
Under prooxidant conditions carotenoid epoxides and cyclic perox-
ides are generated which are chemically unstable and cleaved in sub-
sequent reactions. Major decomposition products from carotenoids 
under oxidative conditions are ketones and aldehydes and it has been 
speculated that reactive cleavage products modify proteins via Schiff- 
base or Michael-type reactions. Thus, not only direct but also indirect 
prooxidant damage may occur. Cleavage products obtained in enzyme- 
mediated metabolic processes like apo-carotenals retain the structure of 
biologically active signalling molecules and may trigger signaling 
pathways [44]. Chemical modification of thiol groups in regulatory 
molecules triggers further transcription systems, such as the 
electrophile-antioxidant response element pathway and nuclear 
factor-κB [45]. The complex interaction of carotenoids and their me-
tabolites with cellular targets involved in adipose tissue biology has 
recently been reviewed [46]. 
3.3. Carotenoids and cognition 
Carotenoids are differentially distributed in various organs of the 
human body. Interestingly, xanthophylls account for 66–77% of the 
total carotenoids in the frontal and occipital lobes of the human brain, 
whereas less than 40% of the total carotenoids in most tissues and 
plasma are reported to be xanthophylls [29]. Among the carotenoids, 
lutein and zeaxanthin are the only two that cross the blood-retina barrier 
to form macular pigment in the eye [37] and lutein is the dominant 
carotenoid in human brain tissue [37,47]. Lutein is the major carotenoid 
in brain tissue despite not being the major carotenoid in matched serum, 
indicating the preferential uptake into brain tissue [48]. Lutein and 
zeaxanthin in macula were found to be significantly correlated with 
their levels in matched brain tissue [49], Macular pigment can be 
therefore used as a biomarker in brain tissue, and in fact a significant 
correlation was found between macular pigment density and global 
cognitive function in healthy older adults [50,51]. Examination of a 
relationship between cognition and lutein levels in brain tissue of de-
cedents from a population-based study of adults found that lutein was 
consistently associated with a wide range of cognitive measures that 
included executive function, language, learning, and memory, which are 
all associated with specific brain regions [47]. Similarly, a relationship 
was recently found between levels serum and brain levels of carotenoids 
(lutein, zeaxanthin, cryptoxanthin, β-carotene), α-, γ-tocopherols, total 
n-3 polyunsaturated fatty acids (PUFAs), and n-6/n-3 PUFA in partici-
pants in the Georgia Centenarian Study [52]. As no significant rela-
tionship was identified between serum and brain retinol, total saturated 
fatty acid, total monounsaturated fatty acid, and trans-fatty acid levels, 
the authors concluded that serum carotenoids, tocopherols, total n-3 
PUFAs, and n-6/n-3 PUFA ratio reflect levels in brain and might be used 
as surrogate biomarkers in older persons. Others have shown that 
chronic administration of the oxocarotenoid lycopene significantly re-
stores the mitochondrial respiratory enzyme activities in Aβ42 treated 
rats and attenuated mitochondrial oxidative stress [53], suggesting a 
role for carotenoids in maintaining mitochondrial integrity in the brain. 
In line with these findings, we showed that selected tocopherols and 
carotenoids are associated to global cognition measures and biomarkers 
of oxidative stress in healthy persons independent of age, sex and fruit/ 
vegetable intake, suggesting a protective role of these substances even in 
the absence of disease [54,55]. More recently, longitudinal data from 
1251 participants in the Healthy Aging in Neighborhoods of Diversity 
across the Life Span (HANDLS) study (Age at visit 1 in 2004–2009 (v1): 
30–65 years) showed an interaction between total (and individual) ca-
rotenoids for three of 11 cognitive tests at v1, with only one meeting the 
statistical significance upon multiple testing correction whereby vitamin 
E was linked with greater verbal memory performance in the uppermost 
total carotenoid tertile (p = 0.002), a synergism largely driven by 
carotenoid lycopene [56]. In another study, among 927 participants 
from the Rush Memory and Aging Project free from AD at baseline and 
followed up for a mean of 7 y, a higher intake of total carotenoids was 
associated with substantially lower hazard of AD after controlling for 
age, sex, education, ApoE-ε4, participation in cognitively stimulating 
activities, and physical activity level [57]. In this study, among the 
deceased participants, consumers of higher total carotenoids had less 
global AD pathology (b: -0.10; SE = 0.04; P-trend = 0.01). While 
lutein-zeaxanthin and lycopene were inversely associated with brain 
global pathology, lutein-zeaxanthin showed inverse associations also 
with neuritic plaque severity as well as neurofibrillary tangle density 
and severity [57]; the authors concluded that the possible beneficial role 
of total carotenoid consumption, in particular lutein/zeaxanthin, on AD 
incidence may be related to the inhibition of brain β-amyloid deposition 
and fibril formation. 
The systemic metabolic deficit that frequently accompanies the 
development of dementia has also been explored in respect to circu-
lating carotenoid concentrations. Consistently, generic markers of lipid 
peroxidation are increased and carotenoids are depleted in AD serum. 
Our own work has shown that lutein, lycopene, and zeaxanthin con-
centrations were significantly lower in AD patients with vascular co- 
morbidities compared to healthy subjects [58,59]. 
A comparison of serum lipid oxidation between AD and age-matched 
control subjects before and after six-month carotenoid supplementation 
showed higher serum levels of the novel oxidized phospholipid 
biomarker 1-palmitoyl-2-(5′-oxo-valeroyl)-sn-glycero-3-phosphocholine 
(POVPC) analysed using electrospray ionisation tandem mass spec-
trometry (MS) with multiple reaction monitoring (MRM) compared to 
age-matched controls, (p = 0.017). Cognitive function was correlated 
inversely with POVPC (r = − 0.37; p = 0.04). After six months of 
carotenoid intervention, serum POVPC was not different in AD patients 
compared to healthy controls. However, POVPC was significantly higher 
in control subjects after six months of carotenoid intervention compared 
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to their baseline (p = 0.03) [60]. In agreement with this, 20 μM POVPC 
was recently shown to induce loss of GSH and a mitochondrial bio-
energetic deficit in neuronal cells that was not mitigated by oxocar-
otenoids [61]. In this study, since oxocarotenoids are normally 
metabolized in mitochondria, we investigated whether non-toxic 
POVPC concentrations impair mitochondrial metabolism in differenti-
ated (d)SH-SY5Y neuronal cells and whether there is any protective role 
for oxocarotenoids against mitochondrial dysfunction. Following de-
livery of lutein (0.1–1 μM) and zeaxanthin (0.5–5 μM) over 24 h in vitro, 
the increase in mitochondrial ROS production induced by POVPC was 
prevented. We observed that carotenoids protected against uncoupling 
although did not restore ATP production that was induced by high 
concentrations of POVPC [61]. 
The above cited association of circulating carotenoids with cognitive 
performance in healthy persons [55] and AD patients with and without 
vascular comorbidities [56,58,59,62], therefore, appears to be at least in 
part mediated by protective effects exerted by carotenoids against lipid 
peroxidation [60,61]. Together with these observations and with the 
report of a preferential uptake of specific carotenoids in the central 
nervous system [32,37,44,47–53], the association between carotenoid 
intake and dementia risk prior to AD onset [57] strongly supports a 
physiological protective role of carotenoids in the brain beyond the 
expected function of nutritional indicator. Indeed, our own research 
showed that plasma concentrations of lutein, zeaxanthin and α-carotene 
are similarly depleted in patients with AD and with MCI, considered the 
prodromic phase of AD [63], pointing at carotenoid deficiency not 
simply as an epiphenomenon of advanced neurodegeneration. 
Carotenoids appear therefore to possess a privileged position among 
micronutrients as far as central nervous system pathophysiology and 
protection against dementia are concerned, and recent studies deeper 
explored their role in this sense. Among the up to 331 candidate (bio) 
markers investigated in the MARK-Age study in 2220 randomly 
recruited age-stratified persons, lower levels of β-cryptoxanthin and 
zeaxanthin were found, in those who were physically, cognitively or 
psychologically frail [64]. In this study, after adjustment for con-
founders, levels of these carotenoids were inversely associated with the 
risk of being affected by cognitive frailty, i.e. when scoring below the 
10th percentile on global cognitive functioning. Frailty, defined as a 
state of increased vulnerability of the aging body due to diminished 
homeostatic reserves and resistance to cope with endogenous stressors 
[65], is in the meanwhile recognized as a multidimensional, dynamic 
condition [66,67]. Although frailty is strongly associated with adverse 
clinical outcomes and is therefore associated with a high individual and 
socioeconomic burden [66,67], it is not systematically diagnosed in 
clinical routine and therefore no prevention and therapy is structurally 
implemented. Due to the recent advances in the pathophysiology and 
molecular biology of frailty, however, carotenoids are recognized as 
relevant biomarkers of frailty, also in the frame of anorexia of aging and 
as indicators of inflammation and oxidative stress involvement [66,67]. 
Nutritional interventions, along with physical exercise and other life-
style strategies, are highly recommended to restore robustness [66,67]. 
In line with this evidence, recently, of the 121 patients with MCI 
included in the NeuroExercise study at the German Sports University in 
Cologne, Germany, 56 had the full dataset including neuropsychological 
assessment, physical fitness analysis as well as plasma levels of micro-
nutrients including retinol, six carotenoids and two tocopherols [68]. 
Significant correlations independently of fruit and vegetable intake were 
found between plasma levels of β-cryptoxanthin and physical perfor-
mance measured by the Timed Up-and-Go Test (p < 0.05), γ-tocopherol 
and number of daily steps (p < 0.01), as well as four out of six measured 
carotenoids – lutein, zeaxanthin, β-cryptoxanthin and β-carotene with 
cognitive performance measured by means of the International Shop-
ping List Test (p < 0.01) [68]. In this study, plasma concentrations of 
several carotenoids were strongly correlated with tasks of the CogState 
battery, a valid gamified computerized testing method sensitively and 
reliably measuring verbal learning and memory [69]. Interestingly, a 
significant association was previously found in persons with subjective 
cognitive impairment (SCI) between the ISLT and the endothelial pe-
ripheral arterial tonometry index (EndoPAT Index), a measure of 
endothelial function [70], considered an important mediator of cogni-
tive impairment [6–8]. Interestingly, in this study, we found that plasma 
levels of β-cryptoxanthin were also correlated with the TUG test, a 
marker of balance and increased fall risk and of physical frailty [71]. 
In spite of this convincing evidence for a role of carotenoids for brain 
and cognitive integrity, intervention studies with single carotenoid 
compounds against onset and progression of cognitive impairment have 
yield conflicting results [72–75]. This is largely due to the above 
mentioned multifactoriality of the ageing process [2,22,23] as well as to 
considerable methodological drawbacks of intervention studies, 
including, among others, use of single compounds in heterogeneous 
populations, different time windows and length of the application, 
different doses, and dishomogeneous inclusion criteria [75,76]. One 
important issue is certainly the timeframe in which antioxidant sup-
plementation begins, in fact, as dementia’s symptomes become overt 
years after begin of the neuropathologic alterations, early administra-
tion, at the latest during the SCI, appears a very meaningful strategy. In 
59 healthy persons between 18 and 25 years participating in a 6-month, 
double-blind, placebo-controlled trial to evaluate the effects of xanto-
phyll supplementation (13 mg or 27 mg/day) on cognitive performance, 
scores for composite memory, verbal memory, sustained attention, 
psychomotor speed, and processing speed all improved significantly in 
the treated compared to the placebo group [77]. In this study, change in 
serum lutein was found to be significantly correlated to change in verbal 
memory, composite memory, and sustained attention, while change in 
serum zeaxanthin isomers was significantly correlated with change in 
verbal memory. For these findings and the significant relationship 
observed between change in BDNF and IL-1β over the course of the 
study, the authors concluded that regular consumption of xantophylls 
may interrupt inflammatory processes and enhance cognition [77]. In 
line with the benefit of early administration during the course of life and 
of cognitive decline, recently a composite supplement containing 
food-derived astaxanthin and sesamin or placebo was administered to 
21 MCI patients [78]. In this RCT, treated patients showed higher psy-
chomotor speed and processing speed compared to the placebo group 
[78]. These beneficial effects on cognitive performance were confirmed 
in further investigations and randomized controlled trials in older per-
sons. In a double-masked, randomized, placebo-controlled trial in 51 
older adults randomized into groups receiving either 12 mg lutein and 
zeaxanthin or placebo, participants receiving the active supplement but 
not controls had statistically significant increases in macular pigment 
optical density as well as improvements in complex attention, cognitive 
flexibility and composite memory [79]. These and other investigations 
also showing effects on brain regions by functional imaging [80–82] 
demonstrate the special role that some carotenoids may play with 
respect to other micronutrients in cognitive performance and warrant a 
great deal of attention as far as preventive and therapeutic measures are 
concerned. 
4. Conclusions and research outlook 
A PubMed search on „carotenoids and cognition“ on December 30th, 
2020, shows that 1 to 7 papers per year where published between 1977 
and 2007, while 60 articles were published on the topic only in 2019. 
This increase of attention is largely due to the demographic explosion 
and related growing prevalence of cognitive decline [3,23] increasing 
awareness on a major public health priority of our time. A fundamental 
factor paving the way to the consolidation of the field of nutritional 
cognitive neuroscience of aging, however, is constituted by rapid ad-
vances in the research on lipophilic micronutrients. In particular, ca-
rotenoids exert biological activities of special importance for the optimal 
function of the brain and maintenancy of robustness and healthy aging 
[83]. To overcome recurrent inconsistencies across within-model 
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observational and pathophysiological investigations (in vitro, animal 
models, humans) as well as across intervention studies, a number of 
actions should be taken (see also Weber et al., Redox biomarkers in dietary 
interventions and nutritional observation studies - From new insights to old 
problems, this issue). First of all, studies on micronutrients, nutrition and 
lifestyle should take into account the multifactoriality of aging, nutri-
genetics, geographical, social and cultural aspects. Secondly, novel 
multidimensional and personalized designs as well as innovative tech-
nology including artificial intelligence and deep learning should be 
considered whenever possible in human studies to help disentangling 
the multifactoriality of aging. Furthermore, upcoming studies on the 
effects of carotenoid supplementation should take into account the 
multiple interactions with other (micro)nutrients and involve a broader 
spectrum of robust biomarkers of both antioxidant status and free 
radical-induced damage. Finally, to ensure a correct interpretability of 
findings, a rigorous clinical characterization of study participants, 
including demographics, frailty status, comorbidities, habits, and labo-
ratory values should always be performed. 
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